Vudalimab Biosimilar – Anti-CTLA4;PDCD1 mAb – Research Grade
Size | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Vudalimab Biosimilar - Anti-CTLA4;PDCD1 mAb - Research Grade |
---|---|
Source | CAS 2329669-72-7 |
Species | Humanized |
Expression system | XtenCHO |
Purity | >85% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3 week if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Applications | ELISA,WB |
Aliases /Synonyms | Vudalimab,ANTI-PD-1/ANTI-CTLA-4 XMAB20717, IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)) AND ANTI-(HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL ANTIBODY, BISPECIFIC,CTLA4;PDCD1,anti-CTLA4;PDCD1 |
Reference | PX-TA1739 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | Bispecific ,IgG1,Kappa;Kappa |
Clonality | Monoclonal Antibody |
Related products
Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.